PRODUCTS CAREERS ABOUT SUPPORT WOMEN’S HEALTH INDEX INVESTORS USA Share Investors Menu NASDAQ: HOLX 74.60 +0.25 (+ 0.34% ) November 24, 2021 2:19 PM Pricing delayed by 20 minutes INVESTOR RELATIONS We are an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. WHY INVEST? Previous Strong Balance Sheet Next LEARN MORE RECENT NEWS Previous November 23, 2021 Hologic to Host Innovative Product Experiences and Medical Education Sessions On-site and Virtually at RSNA 2021 November 22, 2021 Hologic to Webcast Presentation at Upcoming Virtual Investor Conference Next ALL PRESS RELEASES Q4 2021 RESULTS Earnings Release (opens in new window) 10-K (opens in new window) Prepared Remarks (opens in new window) Webcast (opens in new window) ALL QUARTERS LATEST EVENT November 30, 2021 Hologic to present at the 4th Annual Evercore ISI HealthCONx Conference Add to Calendar Webcast (opens in new window) ALL EVENTS Quicklinks opens in a new window Corporate Presentation opens in a new window Fast Facts Proxy Statement (opens in new window) 10-K Report (opens in new window) Investor Relations Contacts MICHAEL WATTS Vice President, Investor Relations and Corporate Communications 858.410.8588 michael.watts@hologic.com RYAN SIMON Vice President, Investor Relations 858.410.8514 ryan.simon@hologic.com FRANCIS PRUELL Director, Investor Relations 508.263.8628 francis.pruell@hologic.com PAULA IZIDORO Senior Investor Relations Specialist 858.410.8904 paula.izidoro@hologic.com Email Alerts News Releases Events Presentations SEC Filings End of Day Stock Quote CONTACT PRIVACY POLICY TERMS & CONDITIONS PATENT INFO © Copyright 2021 Hologic Inc. All rights reserved. Powered By Q4 Inc. 5.56.0.1 (opens in new window)